HANSOH PHARMA's stabilization price period ends, and the over-allotment option becomes invalid
HANSOH PHARMA - B (03378.HK) announced that the stabilization period for the global offering ended on January 17. During this period, the stabilization agent did not take any stabilization actions. In addition, the over-allotment option was not exercised and has lapsed on the same day
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments